ClinicalTrials.Veeva

Menu

NENCA Study on Neurological Complications of Long COVID-19 in Children and Adolescents; Neurophysiological, Electroencephalographic and Neuroradiological Investigation

A

Azienda Ospedaliero, Universitaria Pisana

Status

Enrolling

Conditions

Long Covid-19

Treatments

Diagnostic Test: Psychological tests, EEG, Magnetic Resonance

Study type

Interventional

Funder types

Other

Identifiers

NCT06876948
GR-2021-1237536
D65E2000350001 (Other Grant/Funding Number)

Details and patient eligibility

About

The study seeks to investigate the neurological effects caused by Covid-19 in children and adolescents in the 6-16 age group. To do this, neuropsychological scales, an EEG and an MRI were used.

Enrollment

100 estimated patients

Sex

All

Ages

6 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 6 years and 16 years and 11 months
  • Symptomatology compatible with long neurological COVID, specifically: persistence or appearance of new neurological signs/symptoms (e.g. fatigue, headache, sleep disturbance, cognitive dysfunction, memory difficulties, emotional or mood disorders, vertigo cognitive dysfunction, memory difficulties, emotional or mood disorders, dizziness, dysautonomia, movement disorders movement disorders, ataxia, tremor, epilepsy, muscle weakness, myalgia, hyposmia, hypogeusia hearing loss or tinnitus and/or sensorimotor deficits such as hypoesthesia, dysesthesia) after three months after established SARS-CoV-2 infection, as well as persistence of these symptoms for at least two months, in the absence of a clear aetiology.
  • Signature of the appropriate Informed Consent by caregiver(s) and patient(s)

Exclusion criteria

  • Poor knowledge of the Italian language or other limitation of verbal communication that compromises the subject's ability to perform neuropsychological tests
  • Need for sedation to perform brain MRI 7 Tesla
  • Neurological or neuropsychiatric disorder diagnosed prior to COVID-19 diagnosis
  • Caregiver's failure to sign consent

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Sequential Assignment

Masking

None (Open label)

100 participants in 1 patient group

Studio NENCA sulle complicanze neurologiche del Long Covid-19 nei bambini e negli adolescenti
Experimental group
Description:
Patients are administered some psychological tests, if they are positive they move on to the next stage, otherwise the patients leave the practice. If they are positive, EEG, MRI and other psychological tests are also administered.
Treatment:
Diagnostic Test: Psychological tests, EEG, Magnetic Resonance

Trial contacts and locations

1

Loading...

Central trial contact

Alessandro Orsini, Dirigente medico

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems